Cardiovascular magnetic resonance imaging: clinical implications in the evaluation of connective tissue diseases

Sophie Mavrogeni1, George Markousis-Mavrogenis1, Loukia Koutsogeorgopoulou2

  • 1Onassis Cardiac Surgery Center, Athens, Greece.

Insights

Cardiovascular magnetic resonance imaging (CMR) offers a noninvasive method for diagnosing heart conditions in connective tissue diseases (CTDs). Despite its benefits in early detection and monitoring, barriers like cost and expert availability hinder widespread clinical use.

Area of Science:

  • Cardiology
  • Radiology
  • Rheumatology

Background:

  • Connective tissue diseases (CTDs) frequently involve serious cardiovascular complications, including myopericarditis, vascular disease, and heart failure.
  • These complications contribute significantly to morbidity and mortality in CTD patients.
  • Early and accurate cardiovascular diagnosis, risk stratification, and treatment monitoring are crucial for managing CTDs.

Purpose of the Study:

  • To evaluate the utility of cardiovascular magnetic resonance imaging (CMR) as a diagnostic tool for cardiovascular involvement in CTDs.
  • To highlight CMR's capabilities in early detection, disease assessment, and treatment monitoring.
  • To discuss the challenges limiting the broader clinical adoption of CMR in this context.

Main Methods:

  • Cardiovascular magnetic resonance imaging (CMR) was employed as a noninvasive, nonradiating diagnostic technique.
  • The study reviewed CMR's application in evaluating various cardiovascular conditions associated with CTDs.
  • Tissue characterization and high spatial resolution capabilities of CMR were considered.

Main Results:

  • CMR has demonstrated success in evaluating diverse cardiovascular conditions, including cardiomyopathies, valvular diseases, and myocardial perfusion.
  • It can detect early, silent cardiovascular lesions and assess disease activity in CTDs.
  • CMR reliably evaluates the impact of cardiac and rheumatic medications on the cardiovascular system.

Conclusions:

  • Cardiovascular magnetic resonance imaging is a versatile, noninvasive tool for diagnosing and managing cardiovascular complications in CTDs.
  • Its ability to provide detailed tissue characterization aids in early detection and risk stratification.
  • Wider adoption is currently limited by factors such as cost, availability, and the need for multidisciplinary expertise.

Related Concept Videos

Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
443
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
541
Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
10.1K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
787
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
448
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
658